Related Experiment Video
Updated: Nov 26, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Abstract:
As the current pandemic continues to affect populations around the globe, the search for a viable vaccine for coronavirus-2019 (COVID-19) continues. However, rather than constantly scrambling to generate a vaccine after an outbreak happens, some researchers are working on what they see as a better approach: developing a broad-acting "pan-coronavirus" vaccine that provides protection from any coronavirus, present or future.
Insights
Researchers are developing a pan-coronavirus vaccine for broad protection against current and future coronaviruses, offering a proactive approach beyond individual outbreak responses.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- The ongoing coronavirus disease 2019 (COVID-19) pandemic highlights the urgent need for effective vaccines.
- Current vaccine development strategies often focus on specific viral strains, requiring rapid adaptation after outbreaks.
Purpose of the Study:
- To explore the development of a universal vaccine offering protection against a wide range of coronaviruses.
- To shift from reactive vaccine development to a proactive strategy against potential future coronavirus threats.
Main Methods:
- Investigating conserved viral targets across the coronavirus family.
- Designing vaccine platforms capable of eliciting broad-spectrum immune responses.
Main Results:
- Identification of potential conserved epitopes suitable for a pan-coronavirus vaccine.
- Preclinical data suggesting the feasibility of broad-acting coronavirus vaccine candidates.
Conclusions:
- A pan-coronavirus vaccine represents a promising strategy to enhance global preparedness for future pandemics.
- This approach could provide long-term protection against emerging and re-emerging coronavirus threats.
Related Concept Videos
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cross-reactivity
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Subviral Agents
Viruses with RNA Genomes

